Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Vitamin D supplements should be used cautiously in sarcoidosis patients, with regular monitoring to avoid high calcium levels.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Trilostane generally improved symptoms in dogs with Cushing's syndrome, but dosage adjustments were needed over time.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.